Drug intelligence / Profile preview

MamaGynial

Development stage: Unknown
Lead developer: Gynial
Modality: Small Molecules
Administration: Oral

Overview

MamaGynial is a vegan dietary supplement developed by the Austrian company Gynial GmbH, specifically designed for women during the preconception phase, pregnancy, and breastfeeding. The formulation provides a comprehensive blend of essential micronutrients, including 600 μg of Quatrefolic® (a highly bioavailable form of folate), plant-based docosahexaenoic acid (DHA) derived from algae oil, vegan vitamin D3, iodine, and zinc. Developed by a multidisciplinary team of gynecologists and nutrition experts, MamaGynial aims to support fetal development—particularly the brain, eyes, and neural tube—while meeting the increased nutritional demands of the mother.

Brand names: MamaGynial

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on MamaGynial.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MamaGynial.

Explore the full profile